(Q45385107)
Statements
Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin (English)
D A Price
M L Schmid
G L Toms
P Donaldson
D Neely